Back

Statin therapy for primary prevention of microvascular complications in patients with heart failure and type 2 diabetes: a target trial emulation

28 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart: pharmacotherapy (1) Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Ami Matsumoto

(Hong Kong)

6 More presentations in this session

Presentation thumbnail
Efficacy of Semaglutide in glycemic control, weight loss, and improving lipid profile- the role of baseline vitamin D levels.
Professor R. Abo Fanne (Hadera, IL)
Abstract Slides Video
Presentation thumbnail
The association between SGLT2 inhibitors and new-onset osteoporosis in patients with type 2 diabetes: a population-based longitudinal cohort study
Doctor C. Chang (Taichung, TW)
Abstract Slides Video
Presentation thumbnail
Parallel disease trajectories of peripheral neurovascular disease and heart failure in type 2 diabetes mellitus: a 12-year prospective follow-up
Doctor D. Andric (Novi Sad, RS)
Abstract Slides Video
Presentation thumbnail
Suboptimal cardioprotective medication prescribing in patients with diabetes and stage B heart failure
Mr M. Hussain (Dundee, GB)
Abstract Slides Video
Presentation thumbnail
Effects of semaglutide and dapagliflozin on natriuretic peptides in type 2 diabetes: a randomized comparative study
Doctor C. Lejonberg (Helsingborg, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes and the heart: pharmacotherapy (1)

The Event

Event poster

ESC Congress 2026

28 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Statin therapy in chronic heart failure with reduced ejection fraction: a post-hoc analysis of T.O.S.C.A. Registry
3 April 2025
thumbnail
Webinar
Prevention of heart failure in diabetic patients at population level
11 June 2025
thumbnail
Congress Presentation
Type 2 diabetes, chronic kidney disease and major cardiovascular events in patients with established coronary artery disease
27 August 2021
thumbnail
Congress Presentation
To improve the quality of secondary prevention strategies in diabetic patients: the BRING-UP Prevention study results
5 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources